| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, Ohio
Requests for reprints: Thomas T. Egelhoff, Department of Physiology and Biophysics, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106-4970. Phone: 216-368-6971; Fax: 216-368-1693; E-mail tte{at}case.edu.
Initial stages of tumor cell metastasis involve an epithelial-mesenchyme transition that involves activation of amoeboid migration and loss of cell-cell adhesion. The actomyosin cytoskeleton has fundamental but poorly understood roles in these events. Myosin II, an abundant force-producing protein, has roles in cell body translocation and retraction of the posterior of the cell during migration. Recent studies have suggested that this protein may also have roles in leading edge protrusive events. The metastasis-promoting protein metastasin-1, a regulator of myosin II assembly, colocalizes with myosin IIA at the leading edge of cancer cells, suggesting direct roles for myosin II in metastatic behavior. We have assessed the roles of specific myosin II isoforms during lamellar spreading of MDA-MB-231 breast cancer cells on extracellular matrix. We find that the two major myosin II isoforms IIA and IIB are both expressed in these cells, and both are recruited dramatically to the lamellar margin during active spreading on fibronectin. There is also a transient increase in regulatory light chain phosphorylation that correlates the recruitment of myosin IIA and myosin IIB into this spreading margin. Pharmacologic inhibition of myosin II or myosin light chain kinase dramatically reduced spreading. Depletion of myosin IIA via small interfering RNA impaired migration but enhanced lamellar spreading, whereas depletion of myosin IIB impaired not only migration but also impaired initial rates of lamellar spreading. These results indicate that both isoforms are critical for the mechanics of cell migration, with myosin IIB seeming to have a preferential role in the mechanics of lamellar protrusion. (Cancer Res 2006; 66(9): 4725-33)
This article has been cited by other articles:
|
|
 |
|
  E. Matteucci, P. Bendinelli, and M. A. Desiderio Nuclear localization of active HGF receptor Met in aggressive MDA-MB231 breast carcinoma cells Carcinogenesis, June 1, 2009; 30(6): 937 - 945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. K. McMichael, R. B. Wysolmerski, and B. S. Lee Regulated Proteolysis of Nonmuscle Myosin IIA Stimulates Osteoclast Fusion J. Biol. Chem., May 1, 2009; 284(18): 12266 - 12275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Babbin, S. Koch, M. Bachar, M.-A. Conti, C. A. Parkos, R. S. Adelstein, A. Nusrat, and A. I. Ivanov Non-Muscle Myosin IIA Differentially Regulates Intestinal Epithelial Cell Restitution and Matrix Invasion Am. J. Pathol., February 1, 2009; 174(2): 436 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ren, H. Jin, C. Bian, H. He, X. Liu, S. Zhang, Y. Wang, and R.-g. Shao MR-1 Modulates Proliferation and Migration of Human Hepatoma HepG2 Cells through Myosin Light Chains-2 (MLC2)/Focal Adhesion Kinase (FAK)/Akt Signaling Pathway J. Biol. Chem., December 19, 2008; 283(51): 35598 - 35605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Wylie and P. D. Chantler Myosin IIC: A Third Molecular Motor Driving Neuronal Dynamics Mol. Biol. Cell, September 1, 2008; 19(9): 3956 - 3968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Beadle, M. C. Assanah, P. Monzo, R. Vallee, S. S. Rosenfeld, and P. Canoll The Role of Myosin II in Glioma Invasion of the Brain Mol. Biol. Cell, August 1, 2008; 19(8): 3357 - 3368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Conti and R. S. Adelstein Nonmuscle myosin II moves in new directions J. Cell Sci., January 1, 2008; 121(1): 11 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Takizawa, R. Ikebe, M. Ikebe, and E. J. Luna Supervillin slows cell spreading by facilitating myosin II activation at the cell periphery J. Cell Sci., November 1, 2007; 120(21): 3792 - 3803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bazzaro, A. Santillan, Z. Lin, T. Tang, M. K. Lee, R. E. Bristow, I.-M. Shih, and R. B.S. Roden Myosin II Co-Chaperone General Cell UNC-45 Overexpression Is Associated with Ovarian Cancer, Rapid Proliferation, and Motility Am. J. Pathol., November 1, 2007; 171(5): 1640 - 1649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. G. Dulyaninova, R. P. House, V. Betapudi, and A. R. Bresnick Myosin-IIA Heavy-Chain Phosphorylation Regulates the Motility of MDA-MB-231 Carcinoma Cells Mol. Biol. Cell, August 1, 2007; 18(8): 3144 - 3155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Gallagher, J. J. Castorino, D. Wang, and N. J. Philp Monocarboxylate Transporter 4 Regulates Maturation and Trafficking of CD147 to the Plasma Membrane in the Metastatic Breast Cancer Cell Line MDA-MB-231 Cancer Res., May 1, 2007; 67(9): 4182 - 4189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Sato, M. Takahashi, and M. Yazawa Two Regions of the Tail Are Necessary for the Isoform-specific Functions of Nonmuscle Myosin IIB Mol. Biol. Cell, March 1, 2007; 18(3): 1009 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Jana, S. Kawamoto, and R. S. Adelstein A Specific Isoform of Nonmuscle Myosin II-C Is Required for Cytokinesis in a Tumor Cell Line J. Biol. Chem., August 25, 2006; 281(34): 24662 - 24670. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
